Relapsing multiple sclerosis
Clinical trials for Relapsing multiple sclerosis explained in plain language.
Never miss a new study
Get alerted when new Relapsing multiple sclerosis trials appear
Sign up with your email to follow new studies for Relapsing multiple sclerosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a pill rebuild the Brain's insulation? MS trial puts remyelination to the test
Cure Not yet recruitingResearchers are testing an experimental oral drug called PRO-1562 in healthy adults and in adults with relapsing multiple sclerosis who also have long-term vision damage from chronic optic neuropathy. The trial has two parts: a phase 1 safety and absorption study in healthy volun…
Matched conditions: RELAPSING MULTIPLE SCLEROSIS
Phase 1/2 • Sponsor: Progentos Therapeutics • Aim: Cure
Last updated Sep 19, 2026 00:00 UTC
-
Can a new injection tame relapsing MS?
Disease control Not yet recruitingThis early-stage trial is testing an investigational drug called RO7845860, given as an injection under the skin, in people with relapsing multiple sclerosis (MS). The main goals are to check the drug's safety, how the body handles it, and its effects on immune cells. The study w…
Matched conditions: RELAPSING MULTIPLE SCLEROSIS
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
MS patients switch drugs to save immune defenses
Disease control Not yet recruitingThis study follows 115 adults with multiple sclerosis who are switching from ocrelizumab to ofatumumab because their antibody levels dropped. Researchers want to see if the switch stops or slows that decline over 24 months. The goal is to better manage immune health while still t…
Matched conditions: RELAPSING MULTIPLE SCLEROSIS
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New study aims to find which MS drug better fights fatigue
Knowledge-focused Not yet recruitingThis study will follow 100 adults with multiple sclerosis who are starting either teriflunomide or dimethyl fumarate as part of their routine care. Over 12 months, researchers will measure how well participants can walk and think during sustained activities, along with their repo…
Matched conditions: RELAPSING MULTIPLE SCLEROSIS
Sponsor: TC Erciyes University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC